This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Astellas Pharma Gmbh. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Keisuke Maki: Innovator in Pharmaceutical Chemistry
Introduction
Keisuke Maki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that enhance glucokinase activation. His work is vital for advancing treatments related to metabolic disorders.
Latest Patents
Maki holds a patent for "Substituted pyrazine compounds - Phenylacetamide compounds of the formula having sulfonyl group and cycloalkyl group on the phenyl group and having heteroaryl group on the nitrogen atom in the amide." This innovative compound demonstrates excellent glucokinase activation action, showcasing Maki's expertise in creating effective pharmaceutical solutions. He has 1 patent to his name.
Career Highlights
Keisuke Maki is currently employed at Astellas Pharma GmbH, where he continues to push the boundaries of pharmaceutical research. His work at Astellas has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Maki collaborates with esteemed colleagues such as Yoshiyuki Kido and Akira Kanai. Their combined expertise fosters an environment of innovation and creativity, leading to groundbreaking advancements in their field.
Conclusion
Keisuke Maki's contributions to pharmaceutical chemistry are noteworthy and impactful. His innovative work in glucokinase activation compounds highlights his role as a leading inventor in the industry.